医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2013年
12期
2409-2410,2411
,共3页
乔俊%陈天健%黄小俊%李刚
喬俊%陳天健%黃小俊%李剛
교준%진천건%황소준%리강
骨关节炎%膝/药物疗法
骨關節炎%膝/藥物療法
골관절염%슬/약물요법
Osteoarthritis%Knee/DT
[目的]探讨玻璃酸钠关节腔内注射治疗老年膝骨关节炎的临床疗效。[方法]120例老年膝骨关节炎患者随机分为治疗组及对照组各60例。对照组患者给予基本治疗,包括口服盐酸氨基葡萄糖胶囊以及理疗。治疗组在基本治疗基础上行膝关节腔内注射玻璃酸钠,每周1次,5周为一疗程。比较两组患者JOA评分、关节功能、下肢肌力、步态等情况,记录不良反应发生情况。[结果]和治疗前相比,治疗1个月及治疗3个月后两组患者的膝骨关节JOA评分均有较大改善,且差异有显著性(P<0.01),治疗后3个月,治疗组患者膝骨关节JOA评分改善程度均优于对照组,且差异有显著性(81.65±3.96vs60.58±4.38,P<0.01);治疗后6个月治疗组患者显效率及总有效率明显高于对照组,且差异有显著性(88.33%vs78.33%,P<0.01);和对照组相比,治疗过程中治疗组下肢乏力及血压升高总发生率明显降低,且两组相比较差异有显著性(P<0.05)。[结论]与常规基本治疗相比,膝关节腔内注射玻璃酸钠治疗老年膝骨关节炎更有效,不良反应减少,用药安全,值得临床推广。
[目的]探討玻璃痠鈉關節腔內註射治療老年膝骨關節炎的臨床療效。[方法]120例老年膝骨關節炎患者隨機分為治療組及對照組各60例。對照組患者給予基本治療,包括口服鹽痠氨基葡萄糖膠囊以及理療。治療組在基本治療基礎上行膝關節腔內註射玻璃痠鈉,每週1次,5週為一療程。比較兩組患者JOA評分、關節功能、下肢肌力、步態等情況,記錄不良反應髮生情況。[結果]和治療前相比,治療1箇月及治療3箇月後兩組患者的膝骨關節JOA評分均有較大改善,且差異有顯著性(P<0.01),治療後3箇月,治療組患者膝骨關節JOA評分改善程度均優于對照組,且差異有顯著性(81.65±3.96vs60.58±4.38,P<0.01);治療後6箇月治療組患者顯效率及總有效率明顯高于對照組,且差異有顯著性(88.33%vs78.33%,P<0.01);和對照組相比,治療過程中治療組下肢乏力及血壓升高總髮生率明顯降低,且兩組相比較差異有顯著性(P<0.05)。[結論]與常規基本治療相比,膝關節腔內註射玻璃痠鈉治療老年膝骨關節炎更有效,不良反應減少,用藥安全,值得臨床推廣。
[목적]탐토파리산납관절강내주사치료노년슬골관절염적림상료효。[방법]120례노년슬골관절염환자수궤분위치료조급대조조각60례。대조조환자급여기본치료,포괄구복염산안기포도당효낭이급리료。치료조재기본치료기출상행슬관절강내주사파리산납,매주1차,5주위일료정。비교량조환자JOA평분、관절공능、하지기력、보태등정황,기록불량반응발생정황。[결과]화치료전상비,치료1개월급치료3개월후량조환자적슬골관절JOA평분균유교대개선,차차이유현저성(P<0.01),치료후3개월,치료조환자슬골관절JOA평분개선정도균우우대조조,차차이유현저성(81.65±3.96vs60.58±4.38,P<0.01);치료후6개월치료조환자현효솔급총유효솔명현고우대조조,차차이유현저성(88.33%vs78.33%,P<0.01);화대조조상비,치료과정중치료조하지핍력급혈압승고총발생솔명현강저,차량조상비교차이유현저성(P<0.05)。[결론]여상규기본치료상비,슬관절강내주사파리산납치료노년슬골관절염경유효,불량반응감소,용약안전,치득림상추엄。
[Objective]To explore the clinical efficacy of articular injection of sodium hyaluronate for the treat-ment of senile knee osteoarthritis .[Methods] Totally 120 elderly patients with knee osteoarthritis were randomly divided into treatment group and control group with 60 patients in each group .The control group was given only basic treatment including oral glucosamine hydrochloride capsules and physical therapy .The treatment group was given knee articular injection of sodium hyaluronate on the basis of basic treatment .One course were once a week for 5 weeks .The JOA scores ,joint function ,lower extremity muscle strength and gait were recorded and com-pared between two groups .The incidence of adverse effect was recorded .[Results] Compared with before treat-ment ,knee osteoarthritis JOA scores in two groups 1 month and 3 months after treatment were greatly improved , and there was significant difference( P <0 .01) .The improvement of knee osteoarthritis JOA score in the treat-ment group 1 month and 3 months after treatment was better than the control group ,and there was significant difference( P <0 .01) .The excellence rate and total effective rate in treatment group 6 months after treatment were obviously higher than those in control group ,and there was significant difference ( P < 0 .01) .Compared with the control group ,the overall incidence rate of lower extremity weakness and blood pressure elevation in treatment group during treatment was decreased obviously ,and there was significant difference( P<0 .01) .[Con-clusion]Compared with conventional basic therapy ,knee articular injection of sodium hyaluronate for the treat-ment of senile knee osteoarthritis is more effective ,and reduces the adverse reactions ,and the medication is safety . Therefore ,it is worthy of clinical promotion .